[Skip to Navigation]
Sign In
Correction
April 10, 2024

Error in Title and Text

JAMA Psychiatry. 2024;81(6):634. doi:10.1001/jamapsychiatry.2024.0481

The Original Investigation titled “Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial,”1 published on December 6, 2023, was corrected to revise the study type in the title and text from “a nonrandomized controlled trial” to “a nonrandomized open-label trial.” This article was corrected online.

Reference
1.
Aaronson  ST, van der Vaart  A, Miller  T,  et al.  Single-dose synthetic psilocybin with psychotherapy for treatment-resistant bipolar type II major depressive episodes: a nonrandomized open-label trial.   JAMA Psychiatry. Published online December 6, 2023. doi:10.1001/jamapsychiatry.2023.4685Google ScholarCrossref
×